Download PDF
CC BY-NC-ND 4.0 · Revista Iberoamericana de Cirugía de la Mano 2020; 48(01): 010-019
DOI: 10.1055/s-0040-1712096
Original Articles | Artículos Originales
Thieme Revinter Publicações Ltda Rio de Janeiro, Brazil

Current Trends in the Treatment of Dupuytren Disease in Spain

Article in several languages: English | español
Rafael Sanjuan-Cerveró
1  Orthopedic Surgery and Traumatology Service, Hospital de Denia (Alicante), Alicante, Spain
,
Diego Gómez-Herrero
2  Pharmacy Service, Vithas Hospital 9 de Octubre, Valencia, Spain
3  Pharmacy Doctorate Program, Universidad de Granada, Granada, Spain
,
Carlos Novoa-Parra
1  Orthopedic Surgery and Traumatology Service, Hospital de Denia (Alicante), Alicante, Spain
,
Fernando Peña-Molina
1  Orthopedic Surgery and Traumatology Service, Hospital de Denia (Alicante), Alicante, Spain
,
Nuria Franco-Ferrando
1  Orthopedic Surgery and Traumatology Service, Hospital de Denia (Alicante), Alicante, Spain
› Author Affiliations
Further Information

Publication History

15 September 2019

20 February 2020

Publication Date:
29 May 2020 (online)

  Permissions and Reprints

Abstract

Objective Assessment of the treatment trends of Spanish surgeons in clinical practice by making clinical assumptions in Dupuytren's disease (DD).

Material and Method A survey was sent to the members of the Spanish Society for Surgery of the Hand (Sociedad Española de Cirugía de la Mano, SECMA) posing primary and secondary clinical cases. A relationship is established between the selected treatment, the characteristics of the participating surgeons, and the characteristics of the primary clinical cases. Treatment preferences in recurrences are assessed descriptively.

Results In total, 127 surveys were answered. 62.2% of the participants had experience with the use of collagenase and were the basis of the analysis. In primary cases, surgeons with more practice time tended to choose collagenase as treatment for DD. Surgeons who reported higher frequency of collagenase use (67.4% vs. 25.7%) were up to 6 times more likely to indicate such treatment. The patient's age under 50 years was the variable with the greatest association strength for the choice of collagenase treatment (OR = 3.8; CI95% 1.9–7.6). In recurrences, among all clinical cases, the most common answer given by the surgeons was partial fasciectomy.

Conclusions Partial fasciectomy continues to be the most widely used treatment for DD in Spain. In primary cases, collagenase is an alternative adopted by experienced surgeons, and in treatments for young patients. In recurrences, partial fasciectomy is the preferred technique.

Keywords

dupuytren disease - faciectomy - collagenase - survey - treatment